journal
https://read.qxmd.com/read/38632357/cleavage-and-polyadenylation-machinery-as-a-novel-targetable-vulnerability-for-human-cancer
#1
JOURNAL ARTICLE
Giulia Pagani, Paolo Gandellini
The role of alternative polyadenylation of mRNA in sustaining aggressive features of tumors is quite well established, as it is responsible for the 3'UTR shortening of oncogenes and subsequent relief from miRNA-mediated repression observed in cancer cells. However, the information regarding the vulnerability of cancer cells to the inhibition of cleavage and polyadenylation (CPA) machinery is very scattered. Only few recent reports show the antitumor activity of pharmacological inhibitors of CPSF3, one among CPA factors...
April 17, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38622340/inhibition-of-the-galactosyltransferase-c1galt1-reduces-osteosarcoma-cell-proliferation-by-interfering-with-erk-signaling-and-cell-cycle-progression
#2
JOURNAL ARTICLE
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Novel therapeutic strategies are urgently required for osteosarcoma, given the early age at onset and persistently high mortality rate. Modern transcriptomics techniques can identify differentially expressed genes (DEGs) that may serve as biomarkers and therapeutic targets, so we screened for DEGs in osteosarcoma. We found that osteosarcoma cases could be divided into fair and poor survival groups based on gene expression profiles. Among the genes upregulated in the poor survival group, siRNA-mediated knockdown of the glycosylation-related gene C1GALT1 suppressed osteosarcoma cell proliferation in culture...
April 15, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38609574/crispr-cas-gene-knockouts-to-optimize-engineered-t-cells-for-cancer-immunotherapy
#3
REVIEW
Valentine De Castro, Jeanne Galaine, Romain Loyon, Yann Godet
While CAR-T and tgTCR-T therapies have exhibited noteworthy and promising outcomes in hematologic and solid tumors respectively, a set of distinct challenges remains. Consequently, the quest for novel strategies has become imperative to safeguard and more effectively release the full functions of engineered T cells. These factors are intricately linked to the success of adoptive cell therapy. Recently, CRISPR-based technologies have emerged as a major breakthrough for maintaining T cell functions. These technologies have allowed the discovery of T cells' negative regulators such as specific cell-surface receptors, cell-signaling proteins, and transcription factors that are involved in the development or maintenance of T cell dysfunction...
April 12, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38600122/correction-sprtn-is-involved-in-hepatocellular-carcinoma-development-through-the-er-stress-response
#4
Anja Batel, Mirjana Polović, Mateo Glumac, Oliver Šuman, Stipislav Jadrijević, Bernarda Lozić, Marija Petrović, Bobana Samardžija, Nicholas J Bradshaw, Karlo Skube, Vinko Palada, Mislav Acman, Ivana Marinović Terzić
No abstract text is available yet for this article.
April 10, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38594465/understanding-diagnosing-and-treating-pancreatic-cancer-from-the-perspective-of-telomeres-and-telomerase
#5
REVIEW
Songting Shou, Yuanliang Li, Jiaqin Chen, Xing Zhang, Chuanlong Zhang, Xiaochen Jiang, Fudong Liu, Li Yi, Xiyuan Zhang, En Geer, Zhenqing Pu, Bo Pang
Telomerase is associated with cellular aging, and its presence limits cellular lifespan. Telomerase by preventing telomere shortening can extend the number of cell divisions for cancer cells. In adult pancreatic cells, telomeres gradually shorten, while in precancerous lesions of cancer, telomeres in cells are usually significantly shortened. At this time, telomerase is still in an inactive state, and it is not until before and after the onset of cancer that telomerase is reactivated, causing cancer cells to proliferate...
April 9, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38582787/revcar-expressing-immune-effector-cells-for-targeting-of-fn14-positive-glioblastoma
#6
JOURNAL ARTICLE
Haidy A Saleh, Nicola Mitwasi, Liliana R Loureiro, Alexandra Kegler, Karla Elizabeth González Soto, Lydia Hoffmann, Eugenia Crespo, Claudia Arndt, Ralf Bergmann, Michael Bachmann, Anja Feldmann
In recent studies, we have established the unique adapter chimeric antigen receptor (CAR) platform RevCAR which uses, as an extracellular CAR domain, a peptide epitope instead of an antibody domain. RevCAR adapters (termed RevCAR target modules, RevTMs) are bispecific antibodies that enable the reversible ON/OFF switch of the RevCAR system, improving the safety compared to conventional CARs. Here, we describe for the first time its use for retargeting of both T and NK-92 cells. In addition, we describe the development and preclinical validation of a novel RevTM for targeting of the fibroblast growth factor-inducible 14 (Fn14) surface receptor which is overexpressed on Glioblastoma (GBM) cells, and therefore serves as a promising target for the treatment of GBM...
April 6, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38555398/sdcbp-modulates-tumor-microenvironment-tumor-progression-and-anti-pd1-efficacy-in-colorectal-cancer
#7
JOURNAL ARTICLE
Jiahua Yu, Shijun Yu, Jin Bai, Zhe Zhu, Yong Gao, Yandong Li
Anti-programmed cell death 1 (aPD1) therapy has yielded limited success in patients with colorectal cancer (CRC). Syndecan binding protein (SDCBP), encodes a PDZ domain-containing protein that is essential for cellular processes, including cell adhesion, migration, and signal transduction. Here, we investigated the effect of SDCBP on tumor progression, immunotherapy, and the tumor microenvironment (TME) in CRC. High expression of SDCBP is associated with non-response to immunotherapy and correlated with poorer disease-free survival (DFS) in CRC patients...
March 30, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38553639/panoptosis-bridging-apoptosis-pyroptosis-and-necroptosis-in-cancer-progression-and-treatment
#8
REVIEW
Jie Gao, Anying Xiong, Jiliu Liu, Xiaolan Li, Junyi Wang, Lei Zhang, Yao Liu, Ying Xiong, Guoping Li, Xiang He
This comprehensive review explores the intricate mechanisms of PANoptosis and its implications in cancer. PANoptosis, a convergence of apoptosis, pyroptosis, and necroptosis, plays a crucial role in cell death and immune response regulation. The study delves into the molecular pathways of each cell death mechanism and their crosstalk within PANoptosis, emphasizing the shared components like caspases and the PANoptosome complex. It highlights the significant role of PANoptosis in various cancers, including respiratory, digestive, genitourinary, gliomas, and breast cancers, showing its impact on tumorigenesis and patient survival rates...
March 29, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38553638/generation-of-glioblastoma-in-mice-engrafted-with-human-cytomegalovirus-infected-astrocytes
#9
JOURNAL ARTICLE
Joris Guyon, Sandy Haidar Ahmad, Ranim El Baba, Mégane Le Quang, Andreas Bikfalvi, Thomas Daubon, Georges Herbein
Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in glioblastoma multiforme (GB). Herewith, we present the first experimental evidence for the generation of CMV-Elicited Glioblastoma Cells (CEGBCs) possessing glioblastoma-like traits that lead to the formation of glioblastoma in orthotopically xenografted mice. In addition to the already reported oncogenic HCMV-DB strain, we isolated three HCMV clinical strains from GB tissues that transformed HAs toward CEGBCs and generated spheroids from CEGBCs that resulted in the appearance of glioblastoma-like tumors in xenografted mice...
March 29, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38548883/gastrointestinal-infections-and-gastrointestinal-haemorrhage-are-underestimated-but-serious-adverse-events-in-chimeric-antigen-receptor-t-cell-recipients-a-real-world-study
#10
JOURNAL ARTICLE
Zhiqiang Song, Yang Wang, Ping Liu, Yuke Geng, Na Liu, Jie Chen, Jianmin Yang
Chimeric antigen receptor T-cell (CAR-T) therapy has achieved durable response in patients with hematological malignancies, however, therapy-associated multisystem toxicities are commonly observed. Here, we systematically analyzed CAR-T-related gastrointestinal adverse events (GAEs) using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) between January 2017 and December 2021. Disproportionality analyses were performed using reporting odds ratios (ROR) and information component (IC)...
March 28, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38532115/enhanced-epithelial-mesenchymal-transition-signatures-are-linked-with-adverse-tumor-microenvironment-angiogenesis-and-worse-survival-in-gastric-cancer
#11
JOURNAL ARTICLE
Masanori Oshi, Arya Mariam Roy, Li Yan, Sachika Kinoshita, Yuko Tamura, Takashi Kosaka, Hirotoshi Akiyama, Chikara Kunisaki, Kazuaki Takabe, Itaru Endo
Epithelial-mesenchymal transition (EMT) is a crucial mechanism that facilitates cancer cell metastasis. Despite its importance, the clinical significance of EMT in gastric cancer (GC) patients has yet to be clearly demonstrated. For gauging the extent of EMT in GC, we employed gene set variation analysis to score 807 patient samples from two large cohorts: TCGA and GSE84437. In both cohorts, EMT high GC showed a significant association with worse overall survival (hazard ratio (HR) = 1.74, p = 0...
March 26, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38632356/mir-124-3p-and-mir-194-5p-regulation-of-the-pi3k-akt-pathway-via-ror2-in-medulloblastoma-progression
#12
JOURNAL ARTICLE
Chen Wang, Runxi Fu, Yunkun Wang, Jia Wei, Ying Yu, Liuhua Hu, Chenran Zhang
Medulloblastoma (MB), a prevalent pediatric central nervous system tumor, is influenced by microRNAs (miRNAs) that impact tumor initiation and progression. However, the specific involvement of miRNAs in MB tumorigenesis remains unclear. Using single-cell RNA sequencing, we identified ROR2 expression in normal human fetal cerebellum. Subsequent analyses, including immunofluorescence, quantitative real-time PCR (qRT-PCR), and Western blot, assessed ROR2 expression in MB tissues and cell lines. We investigated miR-124-3p and miR-194-5p and their regulatory role in ROR2 expression through the dual-luciferase reporter, qRT-PCR, and western blot assays...
March 19, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38499648/heterogeneity-of-hepatocellular-carcinoma-from-mechanisms-to-clinical-implications
#13
REVIEW
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao
Hepatocellular Carcinoma (HCC) is one of the most common types of primary liver cancer. Current treatment options have limited efficacy against this malignancy, primarily owing to difficulties in early detection and the inherent resistance to existing drugs. Tumor heterogeneity is a pivotal factor contributing significantly to treatment resistance and recurrent manifestations of HCC. Intratumoral heterogeneity is an important aspect of the spectrum of complex tumor heterogeneity and contributes to late diagnosis and treatment failure...
March 18, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38499647/hippo-pathway-in-non-small-cell-lung-cancer-mechanisms-potential-targets-and-biomarkers
#14
REVIEW
Hongge Liang, Yan Xu, Jing Zhao, Minjiang Chen, Mengzhao Wang
Lung cancer is the primary contributor to cancer-related deaths globally, and non-small cell lung cancer (NSCLC) constitutes around 85% of all lung cancer cases. Recently, the emergence of targeted therapy and immunotherapy revolutionized the treatment of NSCLC and greatly improved patients' survival. However, drug resistance is inevitable, and extensive research has demonstrated that the Hippo pathway plays a crucial role in the development of drug resistance in NSCLC. The Hippo pathway is a highly conserved signaling pathway that is essential for various biological processes, including organ development, maintenance of epithelial balance, tissue regeneration, wound healing, and immune regulation...
March 18, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38493226/the-pleiotropic-nature-of-nono-a-master-regulator-of-essential-biological-pathways-in-cancers
#15
REVIEW
Domenica Ronchetti, Valentina Traini, Ilaria Silvestris, Giuseppina Fabbiano, Francesco Passamonti, Niccolò Bolli, Elisa Taiana
NONO is a member of the Drosophila behavior/human splicing (DBHS) family of proteins. NONO is a multifunctional protein that acts as a "molecular scaffold" to carry out versatile biological activities in many aspects of gene regulation, cell proliferation, apoptosis, migration, DNA damage repair, and maintaining cellular circadian rhythm coupled to the cell cycle. Besides these physiological activities, emerging evidence strongly indicates that NONO-altered expression levels promote tumorigenesis. In addition, NONO can undergo various post-transcriptional or post-translational modifications, including alternative splicing, phosphorylation, methylation, and acetylation, whose impact on cancer remains largely to be elucidated...
March 16, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38486109/misev2023-shaping-the-future-of-ev-research-by-enhancing-rigour-reproducibility-and-transparency
#16
REVIEW
Mark Samuels, Georgios Giamas
No abstract text is available yet for this article.
March 14, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38480978/the-integrate-profiling-of-single-cell-and-spatial-transcriptome-rna-seq-reveals-tumor-heterogeneity-therapeutic-targets-and-prognostic-subtypes-in-ccrcc
#17
JOURNAL ARTICLE
Yanlong Zhang, Xuefeng Huang, Minghang Yu, Menghan Zhang, Li Zhao, Yong Yan, Liyun Zhang, Xi Wang
Clear-cell renal cell carcinoma (ccRCC) is the most common type of RCC; however, the intratumoral heterogeneity in ccRCC remains unclear. We first identified markers and biological features of each cell cluster using bioinformatics analysis based on single-cell and spatial transcriptome RNA-sequencing data. We found that gene copy number loss on chromosome 3p and amplification on chromosome 5q were common features in ccRCC cells. Meanwhile, NNMT and HILPDA, which are associated with the response to hypoxia and metabolism, are potential therapeutic targets for ccRCC...
March 13, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38480977/caffeic-acid-phenethyl-ester-suppresses-the-expression-of-androgen-receptor-variant-7-via-inhibition-of-cdk1-and-akt
#18
JOURNAL ARTICLE
Ying-Yu Kuo, Chieh Huo, Chia-Yang Li, Chih-Pin Chuu
Androgen receptor (AR) splice variant 7 (AR-V7) is capable to enter nucleus and activate downstream signaling without ligand. AR-V7 assists the tumor growth, cancer metastasis, cancer stemness, and the evolvement of therapy-resistant prostate cancer (PCa). We discovered that caffeic acid phenethyl ester (CAPE) can repress the expression and downstream signaling of AR-V7 in PCa cells. CAPE blocked the gene transcription, nuclear localization, and protein abundance of AR-V7. CAPE inhibited the expression of U2AF65, SF2 and hnRNPF, which were splicing factors for AR-V7 intron...
March 13, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38480976/adeno-associated-virus-mediated-trastuzumab-delivery-to-the-central-nervous-system-for-human-epidermal-growth-factor-receptor-2-brain-metastasis
#19
JOURNAL ARTICLE
Marcela S Werner, Shweta Aras, Ashleigh R Morgan, Jillian Roamer, Nesteene J Param, Kanyin Olagbegi, R Jason Lamontagne, Jenny A Greig, James M Wilson
Trastuzumab improves overall survival for HER2+ breast cancer, but its short half-life in the cerebrospinal fluid (~2-4 days) and delivery limitations restrict the ability to target HER2+ central nervous system (CNS) disease. We developed an adeno-associated virus (AAV) vector expressing a codon-optimized, ubiquitin C (UbC)-promoter-driven trastuzumab sequence (AAV9.UbC.trastuzumab) for intrathecal administration. Transgene expression was evaluated in adult Rag1 knockout mice and rhesus nonhuman primates (NHPs) after a single intracerebroventricular (ICV) or intra-cisterna magna (ICM) AAV9...
March 13, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38480975/romidepsin-exhibits-anti-esophageal-squamous-cell-carcinoma-activity-through-the-ddit4-mtorc1-pathway
#20
JOURNAL ARTICLE
Wei-Feng Xia, Xiao-Li Zheng, Wen-Yi Liu, Yu-Tang Huang, Chun-Jie Wen, Hong-Hao Zhou, Qing-Chen Wu, Lan-Xiang Wu
Esophageal squamous cell carcinoma (ESCC) is one of the most common human malignancies worldwide and is associated with high morbidity and mortality. Current treatment options are limited, highlighting the need for development of novel effective agents. Here, a high-throughput drug screening (HTS) was performed using ESCC cell lines in both two- and three-dimensional culture systems to screen compounds that have anti-ESCC activity. Our screen identified romidepsin, a histone deactylase inhibitor, as a potential anti-ESCC agent...
March 13, 2024: Cancer Gene Therapy
journal
journal
31954
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.